NIH NIBIB eC3i Program - Education 2026: Free 10-Week Biomedical Commercialization Course

NIH NIBIB eC3i Program - Education 2026: Free 10-Week Biomedical Commercialization Course

The NIH NIBIB eC3i Education program is an online entrepreneurial education course for investigators who want to assess whether a biomedical technology can become a compelling commercialization opportunity. The National Institute of Biomedical Imaging and Bioengineering (NIBIB) describes it as an online component of the broader Concept to Clinic: Commercializing Innovation, or C3i, Program. The course supplies business frameworks, online learning, customized mentoring, stakeholder work, and structured presentations rather than a conventional research grant.

This page is a historical reference for the 2026 cycle. The official NIBIB education page says that applications are currently closed. It lists the application due date as April 17, 2026, notice of participation as May 1, 2026, the program start date as June 1, 2026, and the program end date as August 21, 2026. The official page does not announce a later cycle, replacement deadline, or new application window. Do not treat the closed-cycle date below as an open deadline.

Key details

The word “free” in this listing refers to the official statement that participation costs are covered. It should not be read as a promise of a stipend, grant, equity investment, reimbursement, or product-development budget. The page describes training and mentoring. It does not publish a cash amount for selected teams.

What the course is designed to teach

The course starts with the question of whether a biomedical technology addresses an unmet market need and can support a credible business opportunity. Its core learning objectives are to characterize the unmet market need, identify key product attributes, conduct customer and stakeholder interviews, and validate the business opportunity. These objectives apply commercial discipline to a research project without replacing the underlying NIH-funded research.

The online curriculum uses self-learning modules focused on testing commercial viability against broad business criteria and the specific demands of biomedical technology commercialization. Participants also work with business advisors who bring industry experience to the learning objectives. The official page describes several checkpoints during the course. Teams present what they have learned and are expected to prepare a final presentation that assesses their progress against the course objectives.

The structure makes this more demanding than a library of optional videos. Participants need to complete exercises, attend scheduled sessions, speak with people who influence adoption, and bring findings back to the team. A team that wants only a passive introduction to entrepreneurship is a poor fit. A team willing to test its assumptions with potential users, purchasers, payers, partners, or investors can use the course to clarify what must happen before a technology is ready for broader translation.

Eligibility and participating Institutes and Centers

The official eligibility statement is aimed at investigators with active NIH-funded research projects from participating Institutes and Centers. The project should involve a biomedical technology, and the investigator should be interested in assessing whether that technology represents a compelling commercialization opportunity. The page strongly encourages prospective applicants to contact NIH Scientific or Research staff before applying so that project alignment and award eligibility can be checked.

The recommended Project Team has at least two members. One is the inventor or technical lead. The other is a graduate student or post-doctoral candidate involved in the project. The technical lead should be the PD/PI for the parent award project or a co-investigator with in-depth knowledge of the technology or innovation. The graduate student or post-doctoral candidate should have a strong interest in examining the commercial opportunity and could pursue an entrepreneurial role if a company were formed. Team members do not have to be key personnel on the parent award project.

The 2026 page lists these participating organizations and routes questions through their named staff:

• National Cancer Institute (NCI)
• National Heart, Lung, and Blood Institute (NHLBI)
• National Institute on Aging (NIA)
• National Institute of Biomedical Imaging and Bioengineering (NIBIB)
• Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
• National Institute of General Medical Sciences (NIGMS)
• National Institute of Mental Health (NIMH)
• National Institute of Neurological Disorders and Stroke (NINDS)
• National Institute of Nursing Research (NINR)
• Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative awards routed through the relevant NIH Institute or Center

Eligibility is not one universal grant-code rule. The official page lists different award types and activity codes for each participating organization. For NIBIB, the listed active grant activity codes are K99/R00, R01, U01, and P41. Other examples include research, career-development, training, and SBIR/STTR mechanisms for some participating organizations, while some organizations exclude particular mechanisms or direct applicants to another C3i course. The applicant’s parent award, institute, technology, and team should therefore be checked with the appropriate contact before relying on a general description of NIH funding.

The official page names Kari Ashmont for NIBIB and provides NIBIB-SBIR@mail.nih.gov as the program email. Applicants connected to another participating organization should use that organization’s listed Scientific or Research contact. BRAIN Initiative investigators should follow the routing instructions for the Institute that supports the award, with other BRAIN applicants directed to the named NIMH contact.

Participation expectations

The course has a recurring cadence. The page estimates that participants should be able to commit 10-15 hours per week to coursework, webinars, and one-on-one coaching sessions. That estimate is important when deciding whether a team can participate responsibly. Modules and conversations build on each other, so joining without enough time for follow-through would weaken both the team’s learning and the quality of the feedback it can provide.

The course begins with an introductory web conference. Project Teams meet their business advisors and project managers and receive an introduction to concepts and tools for examining the unmet need and business opportunity. The course then combines online exercises with frequent one-on-one meetings. These meetings may take place by web or teleconference, and the team discusses what it is learning from people connected to the proposed product.

Stakeholder interviews are a central part of the work. The official page recommends that a Project Team speak with at least 30 stakeholders to obtain a broad range of perspectives. Depending on the technology, those stakeholders may include health care providers, referring providers, patients, health care payors, purchasing agents or other people with buying authority, strategic partners, and potential investors. The point is not to collect a ceremonial list of conversations. Teams are expected to report how the interviews change or refine their understanding of the unmet need and business opportunity.

After several weeks of interviews, groups of Project Teams join web conferences to share findings. These group calls give participants a chance to present progress, receive coaching, and learn from the broader business-advisor group. The final event is a group web conference with pitch presentations focused on the value proposition and market opportunity. Each team is assigned one business advisor and one project manager, with assignments generally based on the match between the advisor’s experience and the technology area, such as devices, diagnostics, or imaging.

How the application worked for the 2026 cycle

The official NIBIB page linked applicants to an NIH application form while the 2026 window was open. The form identified the parent NIH grant and the people responsible for the submission. The application fields shown on the official form included the NIH grant number, whether the grant was a BRAIN Initiative grant, the grant title, the academic institute or company, the team lead’s name and email, and team-member names and email addresses.

The form also requested concise project responses covering the problem or unmet need, proposed solution, impact or significance, competition, status and intellectual property, key challenges, and team. A CAPTCHA was part of the submission form. These fields indicate the information a future applicant should assemble before a new window is announced, but they are not evidence that submissions are accepted now.

A sound preparation sequence for a future cycle is:

1. Identify the NIH parent award supporting the biomedical technology and confirm that it is active.
2. Match the award’s Institute or Center and activity code against the eligibility section on the official eC3i page.
3. Contact the relevant NIH Scientific or Research staff member to confirm project alignment before drafting a final response.
4. Form the recommended team, making sure the inventor or technical lead and the graduate student or post-doctoral candidate have clear roles.
5. Draft specific responses about the unmet need, proposed solution, impact, competition, intellectual property status, key challenges, and team.
6. Plan how the team will conduct stakeholder interviews and convert what it learns into changes to its commercialization assumptions.
7. Submit through the official NIH form only when a new application window is announced.

For the closed 2026 round, the historical sequence was an application deadline of April 17, 2026, notice of participation on May 1, 2026, a course start on June 1, 2026, and a course end on August 21, 2026. Those dates are retained here so readers can understand the archived cycle. They are not a current invitation to submit.

What successful participation could lead to

The official page says that project teams that successfully complete the eC3i course will be eligible to matriculate into the core C3i Program for continued entrepreneurial training. This is a pathway statement, not a guaranteed acceptance into the core program, a grant award, a company formation decision, or commercial success. Teams should use the education course to improve their understanding of users, buyers, adoption barriers, product attributes, and the evidence needed to support a translation decision.

The course is particularly relevant when the technical work is credible but the team still needs to test who experiences the problem, who makes a purchasing decision, what product attributes matter, and which assumptions could prevent adoption. It can also help a team explain its technology to people outside the laboratory. The presence of a business advisor and the requirement to present findings create opportunities to receive direct questions before a team commits to a commercialization path.

Historical-reference notice

This listing should be read as an archive of the 2026 NIH NIBIB eC3i Education cycle. The official source confirms that applications are currently closed and does not publish a next-cycle date. Anyone interested in a later round should monitor the official NIBIB eC3i page and contact the relevant NIH program staff rather than reuse the archived deadline. The official page is the authority for any future eligibility changes, participating organizations, application form, and timeline.

Official links

• Program page: https://www.nibib.nih.gov/programs/concept-clinic-commercializing-innovation-c3i-program/education
• NIH application form used for the program: https://www.nibib.nih.gov/webform/nih_c3i_application

The official program page is maintained by NIBIB and includes the purpose, eligibility, participating Institutes and Centers, course activities, closed status, 2026 timeline, and program contact. The application form link is included for historical context; its presence does not mean that the closed cycle is accepting submissions.